Zymeworks CEO Discusses New Royalty-Based Model at Citi Annual Global Healthcare Conference 2025
ByAinvest
Wednesday, Dec 3, 2025 11:24 pm ET1min read
ZYME--
Zymeworks Inc. CEO Kenneth Galbraith discussed the company's evolution to a royalty-based model at the Citi Annual Global Healthcare Conference 2025. The change in strategy aims to prioritize pipeline and portfolio development, as well as provide financial benefits. The company recently presented excellent data with partner Jazz, but the CEO emphasized that the royalty model is not a drastic pivot.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet